Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06955286 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Study on the Incidence of Adrenal Insufficiency After Surgery in Primary Aldosteronism Patients Concurrent With or Without Autonomous Cortisol Secretion

StatusRecruiting
PhaseNot specified
SponsorQifu Li
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Enrollment target: 200 to 521v3 Show 5 more changesShow less
    • Primary endpoints: 1 to 3
    • Interventions: complete ACTH stimulation test the day after surgery (Diagnostic Test) to complete ACTH stimulation test the day after surgery and complete ACTH stimulation test 1 or 4 week for patients with Adrenal Insufficiency…
    • Eligibility criteria shortened, about 34 words
    • Study description expanded, about 37 words
    • Study arms: 1 to 3
  2. Study description expanded, about 2 wordsv2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Qifu Li
6 trials monitored
See all monitored trials
To evaluate the incidence of adrenal insufficiency after surgery in Primary aldosteronism (PA) patients concurrent with or without autonomous cortisol secretion (ACS). To assess the recovery time of postoperative adrenal insufficiency in patients. And to explore the clinical characteristics and predictive indicators of patients requiring postoperative hormone replacement therapy.
Trial Details
NCT Number NCT06955286
Lead Sponsor Qifu Li
Conditions
(from sponsor)		 Primary Aldosteronism, Autonomous Cortisol Secretion, Adrenal Insufficiency
Related terms Adrenal Insufficiency, Hyperaldosteronism
Enrollment 521 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov